DCM
EXAS

Dialectic Capital Management’s Exact Sciences EXAS Stock Holding History

Dialectic Capital Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-26,600
Closed -$791K – 158
2015
Q2 		$791K Sell
26,600
-53,400
-67% -$1.34M 0.24% 127
2015
Q1 		$1.76M Buy
+80,000
New +$2.03M 0.31% 107

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return

Dialectic Capital Management's EXAS Position: Q4 2016 in Review

Dialectic Capital Management sold out of Exact Sciences (EXAS) in Q4 2016, closing a stake of 155,000 shares — an estimated $2.88M sold.

Dialectic Capital Management first reported a position in EXAS in Q2 2016 and held it in 2 quarters. The position peaked at $2.88M in Q3 2016. 223 funds tracked by Wall St. Rank hold EXAS as of Q4 2016.

  • Dialectic Capital Management reported no remaining Exact Sciences position as of Q4 2016 after selling out during the quarter.
  • Dialectic Capital Management sold 155,000 Exact Sciences shares in Q4 2016, an estimated $2.88M.
  • Dialectic Capital Management first reported a position in Exact Sciences in Q2 2016 and held it in 2 quarters.
  • Dialectic Capital Management's Exact Sciences position peaked at $2.88M in Q3 2016.
  • 223 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2016.

Based on Dialectic Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.